PR Newswire/Les Echos/
AbbVie Declares Inaugural Dividend
NORTH CHICAGO, Ill., Jan. 4, 2013 -- The board of directors of AbbVie Inc.
(NYSE: ABBV), a global biopharmaceutical company, today declared the Company's
first quarterly cash dividend of $0.40 per share.
The cash dividend is payable Feb. 15, 2013 to stockholders of record at the
close of business on Jan. 15, 2013.
AbbVie began trading on the New York Stock Exchange (NYSE) on Jan. 2, 2013 under
the symbol "ABBV" and was also added to the S&P 500 Index.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed
in 2013 following separation from Abbott. AbbVie combines the focus and passion
of a leading-edge biotech with the expertise and structure of a long-established
pharmaceutical leader. The company's mission is to use its expertise, dedicated
people and unique approach to innovation to develop and market advanced
therapies that address some of the world's most complex and serious diseases.
AbbVie aims to help patients live healthier lives and collaborate on sustainable
healthcare solutions. In 2013, AbbVie will employ approximately 21,000 people
worldwide and market medicines in more than 170 countries. For further
information on the company and its people, portfolio and commitments, please
visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook
or LinkedIn page.
CONTACT: Media, Adelle Infante, +1-847-938-8745, or Investors,
Larry Peepo, +1-847-935-6722
The content and accuracy of news releases published on this site and/or
distributed by PR Newswire or its partners are the sole responsibility of the
originating company or organisation. Whilst every effort is made to ensure the
accuracy of our services, such releases are not actively monitored or reviewed
by PR Newswire or its partners and under no circumstances shall PR Newswire or
its partners be liable for any loss or damage resulting from the use of such
information. All information should be checked prior to publication.
-0- Jan/07/2013 08:11 GMT
Press spacebar to pause and continue. Press esc to stop.